The travel vaccines market is estimated to reach US$ 3,878.94 Million in 2022. As per the report, sales are forecast to increase at a robust 9.8% CAGR, with the market valuation reaching US$ 6,914.22 Million by 2032.
Vaccination is an extremely efficient way of preventing some infectious diseases. Vaccines
are relatively safe, with significant adverse effects being extremely rare. Most of the world’s youngsters are protected from a variety of infectious diseases by the routine immunisation programmes.
Request our report sample Now: https://www.futuremarketinsights.com/reports/sample/rep-gb-3490
Previously, millions of people died each year because of various diseases. Vaccination provides travellers with the option of preventing various infectious diseases that kids may come into contact with, when away from home.
There are several government bodies which are taking constant efforts in order to prevent the spread of diseases. Vaccinations are made mandatory to travellers before crossing the borders. Moreover, there are several pharmaceutical companies that are innovating as well as inventing new vaccinations for the constantly growing infectious diseases.
The players have developed vaccinations that have less dosages to ensure the safety and prevent the side effects caused by the vaccines. Combinations of vaccines are also being used to generate immunity against multiple diseases. The growing incidences of infectious diseases and increasing awareness among travellers will boon the travel vaccines sector in the upcoming times
Request the Full Report Methodology Now: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-3490
Key Takeaways:
- In terms of disease type, covid-19 vaccinations will have great demand in upcoming years.
- By booking channel, the in-person booking segment is anticipated to hold a noteworthy share of nearly ~65%.
- In terms of age group, demand in the age group 0-14 years and 66-75 years will continue gaining traction through 2032.
Key Players
- GlaxoSmithKline plc
- Merck & Co.
- Sanofi
- Novartis AG
- Pfizer Inc.
- Dynavax Technologies
- Emergent BioSolutions Inc.
- Abbott
- Bharat Biotech
- Serum Institute of India
- Takeda
- Chiron
- BioNTech
- Astra Zeneka
- GSK Vaccines
- Moderna
Travel Vaccines Market by Category
By Disease Type, Travel Vaccines Market is segmented as:
- Covid-19
- Ebola
- Influenza
- Hepatitis
- Others
By Booking Channel, Travel Vaccines Market is segmented as:
- Online Booking
- In Person Booking
By Tourist Type, Travel Vaccines Market is segmented as:
- Domestic
- International
By Tour Type, Travel Vaccines Market is segmented as:
- Independent Traveler
- Tour Group
- Package Traveller
By Age Group, Travel Vaccines Market is segmented as:
- 0-14 Years
- 15-25 Years
- 26-35 Years
- 36-45 Years
- 46-55 Years
- 66-75 Years
By Region, Travel Vaccines Market is segmented as:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube